Jeffrey Eisele's Net Worth
$4.56 Million
Who is Jeffrey Eisele?
Jeffrey Eisele has an estimated net worth of $4.56 Million. This is based on reported shares in Apellis Pharmaceuticals, Inc..
SEC CIK
Jeffrey Eisele's CIK is 0001827326
Past Insider Trading and Trends
2021 was Jeffrey Eisele's most active year for acquiring shares with 4 total transactions. Jeffrey Eisele's most active month to acquire stocks was the month of December. 2023 was Jeffrey Eisele's most active year for disposing of shares, totalling 6 transactions. Jeffrey Eisele's most active month to dispose stocks was the month of December. 2023 saw Jeffrey Eisele paying a total of $1,867,955.52 for 81,961 shares, this is the most they've acquired in one year. In 2023 Jeffrey Eisele cashed out on 10,233 shares for a total of $564,239.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $68
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.14% | -1.25K |
$65.22 | -$81,524.19 | 57.21K |
Scheduled
|
Jan 29 - Jan 30
| ||
Form 4
| -11.21% | -7.38K |
$63.69 | -$469,904.82 | 58.46K |
Scheduled
|
Jan 23
| ||
Form 4
| -2.38% | -1.61K |
$65.00 | -$104,448.57 | 65.84K |
Jan 22
| |||
Form 4
| -7.17% | -5.21K |
$65.58 | -$341,475.06 | 67.44K |
Scheduled
|
Jan 17
| ||
Form 4
| +35.59% | 19.07K |
$66.81 | -$29,262.17 | 72.65K |
Jan 16
| |||
Form 4
| -0.56% | -303.00 |
$59.70 | -$18,088.59 | 53.58K |
Scheduled
|
Dec 26 - Dec 27
| ||
Form 4
| -2.96% | -1.65K |
$68.76 | -$113,178.96 | 53.88K |
Scheduled
|
Feb 23
| ||
Form 4
| +19.50% | 9.06K |
$58.50 | -$48,262.50 | 55.53K |
Feb 21
| |||
Form 4
| -1.86% | -883.00 |
$52.76 | -$46,587.08 | 46.47K |
Scheduled
|
Jan 30
| ||
Form 4
| -0.77% | -367.00 |
$52.77 | -$19,366.59 | 47.35K |
Jan 27
| |||
Form 4
| -8.58% | -4.48K |
$51.58 | -$231,026.82 | 47.72K |
Scheduled
|
Jan 23
| ||
Form 4
| -3.75% | -2.03K |
$52.05 | -$105,817.65 | 52.2K |
Jan 20
| |||
Form 4
| +71.34% | 22.58K |
—
|
—
| 54.23K |
Jan 12
| |||
Form 4
| -4.06% | -1.34K |
$51.68 | -$4,599.52 | 31.65K |
Apr 25 - Dec 22
| |||
Form 4
| -1.30% | -434.00 |
$38.59 | -$16,748.06 | 32.99K |
Jan 28
| |||
Form 4
| +353.38% | 26.05K |
—
|
—
| 33.42K |
Jan 21
| |||
Form 4
| -1.19% | -89.00 |
$47.82 | -$4,255.98 | 7.37K |
Dec 22
| |||
Form 4
| +20.13% | 1.25K |
—
|
—
| 7.46K |
Mar 1
| |||
Form 4
| +412.88% | 5K |
—
|
—
| 6.21K |
Jan 28
| |||
Form 4
|
∞
| 1.21K |
—
|
—
| 1.21K |
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||